Evolutionary dissection of mtDNA hg H: a susceptibility factor for hypertrophic cardiomyopathy

References

• Andersen PS, Havndrup O, Bundgaard H, Larsen LA, Vuust J, Pedersen AK, Kjeldsen K, Christiansen M. 2004. Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency. Eur J Hum Genet. 12(8):673–677.
   PubMed Web of Science ®Google Scholar
• Andersen PS, Havndrup O, Hougs L, Sorensen KM, Jensen M, Larsen LA, Hedley P, Thomsen AR, Moolman-Smook J, Christiansen M, et al. 2009. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat. 30(3):363–370.
   PubMed Web of Science ®Google Scholar
• Andersen PS, Hedley PL, Page SP, Syrris P, Moolman-Smook JC, McKenna WJ, Elliott PM, Christiansen M. 2012. A novel myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivity. Biochem Res Int. 2012:685108.
   PubMedGoogle Scholar
• Bates MGD, Bourke JP, Giordano C, d'Amati G, Turnbull DM, Taylor RW. 2012. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J. 33(24):3023–3033.
   PubMed Web of Science ®Google Scholar
• Bybjerg-Grauholm J, Hagen CM, Goncalves VF, Baekvad-Hansen M, Hansen CS, Hedley PL, Kanters JK, Nielsen J, Theisen M, Mors O, Kennedy , et al. 2017. Mitochondrial DNA SNPs associated with schizophrenia exbibit highly variable inter-allelic haplogroup affiliation and nuclear genogeographic affinity bi-genomic linkage disequilibrium raises major concerns for link to disease. doi: https://doi.org/10.1101/149070. https://www.biorxiv.org/content/10.1101/149070v1
   Google Scholar
• Bybjerg-Grauholm J, Hagen CM, Gonçalves VF, Baekvad-Hansen M, Hansen CS, Hedley PL, Kanters JK, Nielsen J, Theisen M, Mors O, et al. 2018. Complex spatio-temporal distribution and genomic ancestry of mitochondrial DNA haplogroups in 24,216 Danes. PLoS One. 13(12):e0208829.
   PubMed Web of Science ®Google Scholar
• Calvo SE, Mootha VK. 2010. The mitochondrial proteome and human disease. Annu Rev Genomics Hum Genet. 11:25–44.
   PubMed Web of Science ®Google Scholar
• Castro MG, Huerta C, Reguero JR, Soto MI, Domenech E, Alvarez V, Gomez-Zaera M, Nunes V, Gonzalez P, Corao A, et al. 2006. Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int J Cardiol. 112(2):202–206.
   PubMed Web of Science ®Google Scholar
• Chinnery PF, Elliott HR, Syed A, Rothwell PM. 2010. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol. 9(5):498–503.
   PubMed Web of Science ®Google Scholar
• Choi Y, Lee JH, Cui MN, Lee YS, Jung MH, Yi JE, Jung HO, Youn HJ. 2016. Hypertrophic cardiomyopathy attributable to mitochondrial DNA mutation diagnosed by pathology and gene sequencing. Circulation. 133(13):1297–1299.
   PubMed Web of Science ®Google Scholar
• Christiansen M, Hagen CM, Hedley PL. 2015. Mitochondrial haplogroups are associated with hypertrophic cardiomyopathy in the Indian population. Mitochondrion, in Press. 20:105–106.
   PubMed Web of Science ®Google Scholar
• Christiansen M, Hagen CM, Hedley PL. 2015. Mitochondrial haplogroups are associated with hypertrophic cardiomyopathy in the Indian population. Mitochondrion. 20:105–106.
   PubMed Web of Science ®Google Scholar
• Drago I, Pizzo P, Pozzan T. 2011. After half a century mitochondrial calcium in- and efflux machineries reveal themselves. Embo J. 30(20):4119–4125.
   PubMed Web of Science ®Google Scholar
• Elson JL, Andrews RM, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. 2001. Analysis of European mtDNAs for recombination. Am J Hum Genet. 68(1):145–153.
   PubMed Web of Science ®Google Scholar
• Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson JA, Beal MF, Turnbull DM, Howell N. 2006. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum Genet. 119(3):241–254.
   PubMed Web of Science ®Google Scholar
• Elson JL, Majamaa K, Howell N, Chinnery PF. 2007. Associating mitochondrial DNA variation with complex traits. Am J Hum Genet. 80(2):378–382. author reply 382–373.
   PubMed Web of Science ®Google Scholar
• Fernandez-Caggiano M, Barallobre-Barreiro J, Rego-Perez I, Crespo-Leiro MG, Paniagua MJ, Grille Z, Blanco FJ, Domenech N. 2012. Mitochondrial haplogroups H and J: risk and protective factors for ischemic cardiomyopathy. PLoS One. 7(8):e44128.
   PubMed Web of Science ®Google Scholar
• Fernandez-Caggiano M, Barallobre-Barreiro J, Rego-Perez I, Crespo-Leiro MG, Paniagua MJ, Grille Z, Blanco FJ, Domenech N. 2013. Mitochondrial DNA haplogroup H as a risk factor for idiopathic dilated cardiomyopathy in Spanish population. Mitochondrion. 13(4):263–268.
   PubMed Web of Science ®Google Scholar
• Finsterer J, Kothari S. 2014. Cardiac manifestations of primary mitochondrial disorders. Int J Cardiol. 177(3):754–763.
   PubMed Web of Science ®Google Scholar
• Gomez-Duran A, Pacheu-Grau D, Lopez-Gallardo E, Diez-Sanchez C, Montoya J, Lopez-Perez MJ, Ruiz-Pesini E. 2010. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet. 19(17):3343–3353.
   PubMed Web of Science ®Google Scholar
• Govindaraj P, Khan NA, Rani B, Rani DS, Selvaraj P, Jyothi V, Bahl A, Narasimhan C, Rakshak D, Premkumar K, et al. 2014. Mitochondrial DNA variations associated with hypertrophic cardiomyopathy. Mitochondrion. 16:65–72.
   PubMed Web of Science ®Google Scholar
• Hagen CM, Aidt FH, Havndrup O, Hedley PL, Jespersgaard C, Jensen M, Kanters JK, Moolman-Smook JC, Moller DV, Bundgaard H, et al. 2013. MT-CYB mutations in hypertrophic cardiomyopathy. Mol Genet Genomic Med. 1(1):54–65.
   PubMedGoogle Scholar
• Hagen CM, Aidt FH, Hedley PL, Jensen MK, Havndrup O, Kanters JK, Moolman-Smook JC, Larsen SO, Bundgaard H, Christiansen M. 2013. Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population. PLoS One. 8(8):e71904.
   PubMed Web of Science ®Google Scholar
• Hagen CM, Gonçalves VF, Hedley PL, Bybjerg-Grauholm J, Baekvad-Hansen M, Hansen CS, Kanters JK, Nielsen J, Mors O, Demur AB, et al. 2018. Schizophrenia-associated mt-DNA SNPs exhibit highly variable haplogroup affiliation and nuclear ancestry: Bi-genomic dependence raises major concerns for link to disease. PLoS One. 13(12):e0208828.
   PubMed Web of Science ®Google Scholar
• Havndrup O, Christiansen M, Stoevring B, Jensen M, Hoffman-Bang J, Andersen PS, Hasholt L, Norremolle A, Feldt-Rasmussen U, Kober L, et al. 2010. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail. 12(6):535–540.
   PubMed Web of Science ®Google Scholar
• Hedley PL, Haundrup O, Andersen PS, Aidt FH, Jensen M, Moolman-Smook JC, Bundgaard H, Christiansen M. 2011. The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study. J Negat Results Biomed. 10:12.
   PubMedGoogle Scholar
• Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, et al. 2002. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet. 70(5):1152–1171.
   PubMed Web of Science ®Google Scholar
• Hudson G, Carelli V, Spruijt L, Gerards M, Mowbray C, Achilli A, Pyle A, Elson J, Howell N, La Morgia C, et al. 2007. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet. 81(2):228–233.
   PubMed Web of Science ®Google Scholar
• Hudson G, Gomez-Duran A, Wilson IJ, Chinnery PF. 2014. Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases. PLoS Genet. 10(5):e1004369.
   PubMed Web of Science ®Google Scholar
• Jensen MK, Havndrup O, Christiansen M, Andersen PS, Diness B, Axelsson A, Skovby F, Kober L, Bundgaard H. 2013. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation. 127(1):48–54.
   PubMed Web of Science ®Google Scholar
• Larsen S, Diez-Sanchez C, Rabol R, Ara I, Dela F, Helge JW. 2014. Increased intrinsic mitochondrial function in humans with mitochondrial haplogroup H. Biochim Biophys Acta. 1837(2):226–231.
   PubMed Web of Science ®Google Scholar
• Li S, Besenbacher S, Li Y, Kristiansen K, Grarup N, Albrechtsen A, Sparso T, Korneliussen T, Hansen T, Wang J, et al. 2014. Variation and association to diabetes in 2000 full mtDNA sequences mined from an exome study in a Danish population. Eur J Hum Genet. 22(8):1040–1045.
   PubMed Web of Science ®Google Scholar
• Li D, Sun Y, Zhuang Q, Song Y, Wu B, Jia Z, Pan H, Zhou H, Hu S, Zhang B, et al. 2019. Mitochondrial dysfunction caused by m.2336T > C mutation with hypertrophic cardiomyopathy in cybrid cell lines. Mitochondrion. 46:313–320.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Maron MS. 2013. Hypertrophic cardiomyopathy. Lancet. 381(9862):242–255.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart A, et al.; Council on Epidemiology and Prevention. 2006. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation. 113(14):1807–1816.
   PubMed Web of Science ®Google Scholar
• Martinez-Redondo D, Marcuello A, Casajus JA, Ara I, Dahmani Y, Montoya J, Ruiz-Pesini E, Lopez-Perez MJ, Diez-Sanchez C. 2010. Human mitochondrial haplogroup H: the highest VO2max consumer-is it a paradox? Mitochondrion. 10(2):102–107.
   PubMed Web of Science ®Google Scholar
• McFarland R, Clark KM, Morris AA, Taylor RW, Macphail S, Lightowlers RN, Turnbull DM. 2002. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet. 30(2):145–146.
   PubMed Web of Science ®Google Scholar
• mtDNA Variation and Analysis Using Mitomap and Mitomaster. Lott MT, Leipzig JN, Derbeneva O, Xie HM, Chalkia D, Sarmady M, Procaccio V, Wallace DC. Curr Protoc Bioinformatics. 2013 Dec;44(123):1.23.1-26. doi: 10.1002/0471250953.bi0123s44. PMID: 25489354
   Google Scholar
• O'Keefe H, Queen RA, Meldau S, Lord P, Elson JL. 2018. Haplogroup context is less important in the penetrance of mitochondrial DNA complex I mutations compared to mt-tRNA mutations. J Mol Evol. 86(6):395–403.
   PubMed Web of Science ®Google Scholar
• Ong SB, Kalkhoran SB, Cabrera-Fuentes HA, Hausenloy DJ. 2015. Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease. Eur J Pharmacol. 763(Pt A):104–114.
   PubMed Web of Science ®Google Scholar
• Perli E, Giordano C, Tuppen HA, Montopoli M, Montanari A, Orlandi M, Pisano A, Catanzaro D, Caparrotta L, Musumeci B, et al. 2012. Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T > C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy. Hum Mol Genet. 21(1):85–100.
   PubMed Web of Science ®Google Scholar
• Pienaar IS, Howell N, Elson JL. 2017. MutPred mutational load analysis shows mildly deleterious mitochondrial DNA variants are not more prevalent in Alzheimer's patients, but may be under-represented in healthy older individuals . Mitochondrion. 34:141–146.
   PubMed Web of Science ®Google Scholar
• Piotrowska-Nowak A, Elson JL, Sobczyk-Kopciol A, Piwonska A, Puch-Walczak A, Drygas W, Ploski R, Bartnik E, Tonska K. 2018. New mtDNA association model, MutPred variant load, suggests individuals with multiple mildly deleterious mtDNA variants are more likely to suffer from atherosclerosis. Front Genet. 9:702.
   PubMed Web of Science ®Google Scholar
• Putz J, Dupuis B, Sissler M, Florentz C. 2007. Mamit-tRNA, a database of mammalian mitochondrial tRNA primary and secondary structures. RNA (New York, N.Y.). 13(8):1184–1190.
   PubMed Web of Science ®Google Scholar
• Queen RA, Steyn JS, Lord P, Elson JL. 2017. Mitochondrial DNA sequence context in the penetrance of mitochondrial t-RNA mutations: a study across multiple lineages with diagnostic implications. PLoS One. 12(11):e0187862.
   PubMed Web of Science ®Google Scholar
• Raule N, Sevini F, Li S, Barbieri A, Tallaro F, Lomartire L, Vianello D, Montesanto A, Moilanen JS, Bezrukov V, et al. 2014. The co-occurrence of mtDNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, affects human longevity and is population specific. Aging Cell. 13(3):401–407.
   PubMed Web of Science ®Google Scholar
• Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al. 1996. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 93(5):841–842.
   PubMed Web of Science ®Google Scholar
• Rosca MG, Tandler B, Hoppel CL. 2013. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 55:31–41.
   PubMed Web of Science ®Google Scholar
• Strauss KA, DuBiner L, Simon M, Zaragoza M, Sengupta PP, Li P, Narula N, Dreike S, Platt J, Procaccio V, et al. 2013. Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup. Proc Natl Acad Sci USA. 110(9):3453–3458.
   PubMed Web of Science ®Google Scholar
• Teekakirikul P, Kelly MA, Rehm HL, Lakdawala NK, Funke BH. 2013. Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. J Mol Diagn. 15(2):158–170.
   PubMed Web of Science ®Google Scholar
• ten Cate FJ, Hugenholtz PG, van Dorp WG, Roelandt J. 1979. Prevalence of dignostic abnormalities in patients with genetically transmitted asymmetric septal hypertrophy. Am J Cardiol. 43(4):731–737.
   PubMed Web of Science ®Google Scholar
• Towbin JA. 2009. Hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 32(Suppl 2):S23–S31.
   PubMedGoogle Scholar
• Tuppen HA, Blakely EL, Turnbull DM, Taylor RW. 2010. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta. 1797(2):113–128.
   PubMed Web of Science ®Google Scholar
• van der Westhuizen FH, Sinxadi PZ, Dandara C, Smuts I, Riordan G, Meldau S, Malik AN, Sweeney MG, Tsai Y, Towers GW, et al. 2015. Understanding the implications of mitochondrial DNA variation in the health of Black Southern African Populations: The 2014 Workshop. Hum Mutat. 36(5):569–571.
   PubMed Web of Science ®Google Scholar
• van Oven M, Kayser M. 2009. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 30(2):E386–394.
   PubMed Web of Science ®Google Scholar
• Venter M, Tomas C, Pienaar IS, Strassheim V, Erasmus E, Ng WF, Howell N, Newton JL, Van der Westhuizen FH, Elson JL. 2019. MtDNA population variation in Myalgic encephalomyelitis/chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Sci Rep. 9(1):2914.
   PubMedGoogle Scholar